Live Breaking News & Updates on Diamedica therapeutics inc

Stay updated with breaking news from Diamedica therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results

Conference Call and Webcast November 14 at 8:00 AM Eastern Time / 7:00 AM Central Time



Updated Amendment to Phase 2/3 ReMEDy2 AIS Protocol Aimed at Enhancing Patient Enrollment and Increasing...

South-korea , United-states , China , Netherlands , Japan , Rick-pauls , Techpool-bio-pharma , Jordon-dubow , Exchange-commission , Company-phase , Diamedica-therapeutics-inc , Nasdaq

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Netherlands , South-korea , China , Japan , Jordon-dubow , Scott-kellen , Techpool-bio-pharma , Rick-pauls , Paul-papi , Company-phase , Diamedica-therapeutics-inc

DiaMedica Therapeutics Inc. (DMAC) Tops Q3 EPS by 1c

DiaMedica Therapeutics Inc. (DMAC) Tops Q3 EPS by 1c
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nasdaq , Diamedica-therapeutics-inc , Diamedica-therapeutics ,

DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023

06.11.2023 - DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company currently focused on developing recombinant KLK1 (DM199) for the treatment of acute ischemic stroke, announced today that its third quarter 2023 financial results ...

Diamedica-therapeutics-inc , Nasdaq , Medica-therapeutics , Diamedica-therapeutics-stock , Diamedica-therapeutics-chart , Iamedica-therapeutics-kurs , Iamedica-therapeutics-aktie ,

DiaMedica Therapeutics (NASDAQ:DMAC) Stock Price Down 8.6%

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Free Report) shares fell 8.6% on Monday . The company traded as low as $2.50 and last traded at $2.56. 183,312 shares changed hands during trading, an increase of 113% from the average session volume of 85,998 shares. The stock had previously closed at $2.80. Wall Street Analyst Weigh […]

Diamedica-therapeutics-company-profile , Renaissance-technologies , Citadel-advisors , Dimensional-fund-advisors , Nasdaq , Diamedica-therapeutics-inc , Diamedica-therapeutics , Get-free-report , Medica-therapeutics , Fund-advisors , Street-corp

DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer

DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mercer-university , Georgia , United-states , Atlanta , South-korea , Japan , China , Mumbai , Maharashtra , India , Paul-papi , Rick-pauls

DiaMedica Therapeutics (DMAC) Appoints Ambarish Shah as CTO

DiaMedica Therapeutics (DMAC) Appoints Ambarish Shah as CTO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Georgia , United-states , Atlanta , South-korea , Mumbai , Maharashtra , India , China , Japan , Mercer-university , Paul-papi , Ambarish-shah

DiaMedica Therapeutics to Participate at Lake Street's 7th Annual Best Ideas Growth Conference

DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders, today announced that Rick Pauls, its President and CEO will...

New-york , United-states , Rick-pauls , Diamedica-therapeutics-inc , Nasdaq , Diamedica-therapeutics , Lake-street-capital-market , Annual-best-ideas-growth , Lake-street-capital-markets , Medica-therapeutics , Markets ,